Pre-surgery immunotherapy kept a group of bowel cancer patients cancer-free for nearly three years, while personalized blood tests helped predict treatment response. Patients with a specific form of bowel cancer who received a short course of immunotherapy before surgery, rather than chemotherapy afterward, have remained cancer-free for nearly three years, according to updated findings from [...]

An unusual immune signature in lung cancer has led researchers toward a potential therapy involving tumor microbes and MAIT cells. Bacteria living inside lung tumors may be doing more than simply occupying the tumor environment. In preclinical research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy, researchers found that [...]